Interleukin-1β but not IL-1α binds to fibrinogen and fibrin and has enhanced activity in the bound form

Blood

Volumn 104, Issue 2, 2004, Pages 409-414

  Sahni, Abha ^a,b   Guo, Min ^a   Sahni, Sanjeev K ^a   Francis, Charles W ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRIN; FIBRINOGEN; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; IODINE 125; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOMER; NITRIC OXIDE SYNTHASE; SEPHAROSE; DIAGNOSTIC AGENT; NITRIC OXIDE; RADIOACTIVE IODINE;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD VESSEL INJURY; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SCATCHARD PLOT; BINDING COMPETITION; CELL CULTURE; CYTOLOGY; METABOLISM; PHYSIOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

BINDING, COMPETITIVE; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; FIBRIN; FIBRINOGEN; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-1; IODINE RADIOISOTOPES; NITRIC OXIDE; SEPHAROSE; UMBILICAL VEINS;

EID: 3142620892     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0126     Document Type: Article

References (51)

1. Languino LR, Plescia J, Duperray A, et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell. 1993;73:1423-1434.
2. Rowland FN, Donovan MJ, Picciano PT, Wilner GD, Kreutzer DL. Fibrin-mediated vascular injury: identification of fibrin peptides that mediate endothelial cell retraction. Am J Pathol. 1984;117:418-428.
3. Senior RM, Skogen WF, Griffin GL, Wilner GD, Effects of fibrinogen derivatives upon the inflammatory response: studies with human fibrinopeptide B, J Clin Invest. 1986;77:1014-1019,
4. Dvorak HF, Nagy JA, Berse B, et al. Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation. Ann N Y Acad Sci. 1992; 667:101-111.
5. Chalupowicz DG, Chowdhury ZA, Bach TL, Barsigian C, Martinez J. Fibrin II induces endothelial cell capillary tube formation. J Cell Biol. 1995; 130:207-215.
6. Kaplan KL, Mather T, DeMarco L, Solomon S. Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator. Arteriosclerosis. 1989;9:43-49.
7. Ramsby ML, Kreutzer DL. Fibrin induction of tissue plasminogen activator expression in comeal endothelial cells in vitro. Invest Ophthalmol Vis Sci. 1993;34:3207-3219.
8. Fukao H, Matsumoto H, Ueshima S, Okada K, Matsuo O. Effects of fibrin on the secretion of plasminogen activator inhibitor-1 from endothelial cells and on protein kinase C. Life Sci. 1995;57: 1267-1276.
9. Qi J, Kreutzer DL. Fibrin activation of vascular endothelial cells: induction of IL-8 expression. J Immunol. 1995;155:867-876.
10. Ribes JA, Ni F, Wagner DD, Francis CW. Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain. J Clin Invest. 1989;84:435-442.
11. Bini A, Mesa-Tejada R, Fenoglio JJ Jr, Kudryk B, Kaplan KL. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies. Lab Invest. 1989;60:814-821.
12. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev. 1997;8:253-265.
13. Bevilacqua MP, Pober JS, Majeau GR, Contran RS, Gimbrone MA Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984;160:618-623.
14. Paleolog EM, Crossman DC, McVey JH, Pearson JD. Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells. Blood. 1990;75:688-695.
15. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ. Cytokine activation of vascular endothelium: effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem. 1988;263:5797-5803.
16. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A. 1986;83:3460-3464.
17. Gross SS, Jaffe EA, Levi R, Kilboum RG. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydro-biopterin- dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun. 1991; 178:823-829.
18. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol. 1990;136:1229-1233.
19. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins, Science, 1989;243:1160-1165.
20. Natarajan M, Udden MM, McIntire LV. Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro, Blood. 1996;87:4845-4852.
21. Sahni A, Odrijin T, Francis CW. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem. 1998;273:7554-7559.
22. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood. 2000; 96:3772-3778.
23. Sahni A, Sporn LA, Francis CW. Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2. J Biol Chem. 1999;274: 14936-14941.
24. Sahni A, Baker CA, Sporn LA, Francis CW. Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation. Thromb Haemost. 2000;83:736-741.
25. Zhang JD, Cousens LS, Barr PJ, Sprang SR. Three-dimensional structure of human basic fibroblast growth factor, a structural homotog of interleukin 1 beta [erratum appears in Proc Natl Acad Sci U S A. 1991;88:5477]. Proc Natl Acad Sci U S A. 1991;88:3446-3450.
26. Zhang JD, Cousens LS, Barr PJ, Sprang SR. Three-dimensional structure of human basic fibroblast growth factor, a structural homotog of interleukin 1 beta [erratum appears in Proc Natl Acad Sci U S A. 1991;88:5477]. Proc Natl Acad Sci U S A. 1991;88:3446-3450.
27. Vigers GP, Anderson LJ, Caffes P, Brandhuber BJ. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1 beta. Nature. 1997;386:190-194.
28. Odrljin TM, Rybarczyk BJ, Francis CW, Lawrence SO, Hamaguchi M, Simpson-Haidaris PJ. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain. Biochim Biophys Acta. 1996;1298:69-77.
29. Sahni SK, Van Antwerp DJ, Eremeeva ME, Silverman DJ, Marder VJ, Sporn LA. Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsii. Infect Immun. 1998; 66:1827-1833.
30. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980;107:220-239.
31. Li X, Tupper JC, Bannerman DD, et al. Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells TNF-alpha, inefficient by itself, potentiates IL-1 beta-induced PGHS-2 expression in human pulmonary microvascular endothelial cells: requirement of NF-kappaB and p38 MAPK pathways. Infect Immun. 2003;71:4414-4420.
32. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation [comment]. Science. 2002;298:1241-1245.
33. Xu R, Morales JA, Muniyappa R, Skafar DF, Ram JL, Sowers JR. Interleukin-1 beta-induced nitric oxide production in rat aortic endothelial cells: inhibition by estradiol in normal and high glucose cultures. Life Sci. 1999;64:2451-2462.
34. Sahni A, Altland OD, Francis CW. FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth. J Thromb Haemost. 2003;1: 1304-1310.
35. Peng H, Sahni A, Fay PJ, et al. Identification of a binding site on human FGF-2 for fibrinogen. Blood. 2004;103:2114-2120.
36. Sahni A, Francis CW. Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2. J Thromb Haemost. 2003;1:1271-1277.
37. Borth W, Scheer B, Urbansky A, Luger TA, Sottrup-Jensen L. Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin. J Immunol. 1990;145:3747-3754.
38. Eastgate JA, Symons JA, Duff GW. Identification of an interleukin-1 beta binding protein in human plasma. FEBS Lett. 1990;260:213-216.
39. Cozzolino F, Torcia M, Aldinucci D, et al. Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci U S A. 1990; 87:6487-6491.
40. Thieme TR, Hefeneider SH, Wagner CR, Burger DR. Recombinant murine and human IL 1 alpha bind to human endothelial cells with an equal affinity, but have an unequal ability to induce endothelial cell adherence of lymphocytes. J Immunol. 1987;139:1173-1178.
41. Perez RL, Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells: implications in pulmonary inflammation. J Immunol. 1995;154:1879-1887.
42. Boraschi D, Rambaidi A, Sica A, et al. Endothelial cells express the interleukin-1 receptor type I. Blood. 1991;78:1262-1267.
43. Conforti G, Dominguez-Jimenez C, Zanetti A, et al. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood. 1992;80:437-446.
44. Dejana E, Languino LR, Polentarutti N, et al. Interaction between fibrinogen and cultured endothelial cells: induction of migration and specific binding. J Clin Invest. 1985;75:11-18.
45. Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell. 1995; 6:1349-1365.
46. Sundberg C, Rubin K. Stimulation of betal Integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGF beta-receptors. J Cell Biol. 1996;132:741-752.
47. Schneller M, Vuori K, Ruoslahti E. Alpha V beta 3 integrin associates with activated insulin and PDGF beta receptors and potentiates the biological activity of PDGF. EMBO J. 1997;16:5600-5607.
48. Woodard AS, Garcia-Cardena G, Leong M, Madri JA, Sessa WC, Languino LR. The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J Cell Sci. 1998;111:469-478.
49. Rusnati M, Tanghetti E, Dell'Era P, Gualandris A, Presta M. alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells. Mol Biol Cell. 1997;8:2449-2461.
50. Tanghetti E, Ria R, Dell'Era P, at al. Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial Cell adhesion contacts. Oncogene. 2002;21:3889-3897.
51. Perez RL, Ritzenthaler JD, Roman J. Transcriptional regulation of the interleukin-1 beta promoter via fibrinogen engagement of the CD18 integrin receptor. Am J Respir Cell Mol Biol. 1999;20: 1059-1066.